Atossa Therapeutics, Inc. Announces Appointment of Pharma Industry Veteran Richard Graydon, M.D., Ph.D.
Dr. Graydon will devote all of his professional time to the Atossa clinical programs.
- Dr. Graydon will devote all of his professional time to the Atossa clinical programs.
- Prior to joining Atossa, Dr. Graydon served as Senior Director of Clinical Development at Johnson and Johnson where he was responsible for leading compound development and clinical trial programs for Janssen Pharmaceuticals.
- Dr. Graydon spent time in clinical practice following completion of his specialty training in hematology and oncology at Harvard Massachusetts General Hospital.
- Dr. Graydon is the author of The Genetic Risks of Cancer: The Effects of DNA, Genomics and Inheritance on Aging and Survival.